Anti‐proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: Implication of epidermal growth factor receptor down‐regulation and ceramide production

@article{Mimeault2003AntiproliferativeAA,
  title={Anti‐proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: Implication of epidermal growth factor receptor down‐regulation and ceramide production},
  author={Murielle Mimeault and Nicole Pommery and Nicole Wattez and Christian Bailly and Jean Pierre H{\'e}nichart},
  journal={The Prostate},
  year={2003},
  volume={56}
}
Anandamide (ANA) is an endogenous lipid which acts as a cannabinoid receptor ligand and with potent anticarcinogenic activity in several cancer cell types. 
Synergistic antiproliferative and apoptotic effects induced by mixed epidermal growth factor receptor inhibitor ZD1839 and nitric oxide donor in human prostatic cancer cell lines
TLDR
Whether the combination of ZD1839 with an agent donating nitric oxide (NO•), sodium nitroprusside (SNP) results in a synergy of anticarcinogenic responses on metastatic prostate cancer (PC) cells is investigated. Expand
Non‐THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro‐apoptotic effects and underlying mechanisms
TLDR
Cannabinoid receptor activation induces prostate carcinoma cell apoptosis, but cannabinoids other than Δ9‐tetrahydrocannabinol (THC) have not been investigated, and some of these compounds antagonize transient receptor potential melastatin type‐8 (TRPM8) channels, the expression of which is necessary for androgen receptor (AR)‐dependent PCC survival. Expand
Anandamide induces cell death through lipid rafts in hepatic stellate cells
TLDR
Anandamide selectively blocks proliferation and induces cell death in hepatic stellate cells in HSC, the key cell type of liver fibrogenesis, and its precise molecular mechanism in rat HSC has not been fully elucidated. Expand
Cannabinoid receptor dependent and independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor positive and negative prostate cancer cell lines
TLDR
This poster presents a probabilistic procedure to characterize the immune checkpoints of the central nervous system and shows the importance of knowing these checkpoints in the diagnosis and treatment of cancer. Expand
Potential Upstream Regulators of Cannabinoid Receptor 1 Signaling in Prostate Cancer: A Bayesian Network Analysis of Data From a Tissue Microarray
TLDR
The endocannabinoid system regulates cancer cell proliferation, and in prostate cancer a high cannabinoid CB1 receptor expression is associated with a poor prognosis and information on potential upstream regulators is lacking. Expand
A review of cannabinoids and endocannabinoids as a tool for developing possible anti-neoplastic agents in dogs: Uma revisão
There are several alternatives for treating malign neoplastic growths in dogs, including chemotherapy; however, traditionally used drugs have high levels of toxicity due to their low selectivityExpand
The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2
TLDR
Findings suggest anandamide may be a useful chemopreventive/therapeutic agent for colorectal cancer as it targets cells that are high expressors of COX-2, and may also be used in the eradication of tumour cells that have become resistant to apoptosis. Expand
Roles of Eicosanoids in Prostate Cancer.
TLDR
This review will provide an overview of the roles of eicosanoids and endocannabinoids and their potential as therapeutic targets for prostate cancer treatment. Expand
Synergistic antiproliferative and apoptotic effects induced by epidermal growth factor receptor and protein kinase a inhibitors in human prostatic cancer cell lines
TLDR
The results indicated that the simultaneous inhibition of EGFR and PKA signaling cascades might lead to a more massive apoptotic death of metastatic prostatic cancer cells by increasing ceramide accumulation and activating of caspase cascade of a mitochondrial dependent manner. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 55 REFERENCES
Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaP
TLDR
LNCaP cells (derived from a lymph node carcinoma of the human prostate) contain androgen receptors and show androgen‐responsive growth in vitro, and both compounds independently increased the growth rate 2–3 times. Expand
Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
TLDR
It is shown that intratumoral administration of Δ9-tetrahydrocannabinol and the synthetic cannabinoid agonist WIN-55,212-2 induced a considerable regression of malignant gliomas in Wistar rats and in mice deficient in recombination activating gene 2. Expand
Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo
TLDR
Curcumin (turmeric), used as a dietary ingredient and as a natural anti‐inflammatory agent in India and other Southeast Asian countries, was shown to decrease the proliferative potential and induce the apoptosis potential of both androgen‐dependent and androgens‐independent prostate cancer cells in vitro. Expand
A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells.
TLDR
It is suggested that silymarin may exert a strong anticarcinogenic effect against PCA and that this effect is likely to involve impairment of erbB1-SHC-mediated signaling pathway, induction of CDKIs, and a resultant G1 arrest. Expand
Ceramide‐induced cell death in the prostate cancer cell line LNCaP has both necrotic and apoptotic features
TLDR
The molecular details of ceramide‐induced cell death in LNCaP cells remain to be elucidated, and it is suggested that ceramide may cause either apoptosis or growth arrest in the androgen‐responsive prostate cancer cell line L NCaP. Expand
Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein.
TLDR
The view that curcumin may be a novel modality by which one can interfere with the signal transduction pathways of the prostate cancer cell and prevent it from progressing to its hormone-refractory state is supported. Expand
Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation1.
TLDR
It is reported that β-NGF-induced HBCC proliferation was potently inhibited by the synthetic cannabinoid HU-210, 2-AG, anandamide, and its metabolically stable analogs, but not by the an andamide congener, palmitoylethanolamide, or the selective agonist of CB2 cannabinoid receptors, BML-190. Expand
Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy.
TLDR
The mechanism underlying the resistance of apoptosis-insensitive prostate cancer cells to apoptosis was investigated, and it was established that generation of ceramide in LNCaP cells is independent of the de novo pathway. Expand
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.
TLDR
The data suggest that anandamide blocks human breast cancer cell proliferation through CB1-like receptor-mediated inhibition of endogenous Prolactin action at the level of prolactin receptor. Expand
Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer
  • J. Ware
  • Medicine
  • Cancer and Metastasis Reviews
  • 2004
TLDR
The development of human prostate cancer cell lines which grow and metastasize in immune-deficient rodents is an advance which now permits experimental analysis of the role of these growth factors in prostatic metastasis, particularly to bone. Expand
...
1
2
3
4
5
...